Related Experiment Video
Updated: Aug 21, 2025
09:02
Pre-Conditioning the Airways of Mice with Bleomycin Increases the Efficiency of Orthotopic Lung Cancer Cell Engraftment
Published on: June 28, 2018
13.8K
[Pulmonary fibrosis and lung cancer: between complementarities and specificities]
Juliana Rey Cobo1, Argyro Vraka2, Nahal Mansouri2
1Service de pneumologie, Hôpitaux universitaires de Genève, 1211 Genève 14.
Revue Medicale Suisse
|November 16, 2022
Summary
Lung cancer and interstitial lung disease (ILD) share common pathways but their overlap is poorly understood. Managing these patients is challenging due to treatment risks and poor prognosis.
Area of Science:
- Oncology and Pulmonology
- Pathogenesis of fibrotic lung diseases and lung cancer
Context:
- Lung cancer is a leading cause of cancer mortality globally.
- Diffuse fibrosing interstitial lung diseases (ILD), including idiopathic pulmonary fibrosis (IPF), are significant risk factors for lung cancer.
- ILD diagnosis increases morbidity and mortality risk in lung cancer patients.
Purpose:
- To explore the poorly understood overlapping pathogenesis of lung cancer and fibrosing interstitial lung disease (ILD).
- To highlight the clinical challenges in managing patients with both lung cancer and ILD.
- To underscore the risks associated with lung cancer treatments in ILD patients.
Summary:
- Lung cancer and diffuse fibrosing interstitial lung disease (ILD) share common pathogenic mechanisms, yet the precise overlap remains unclear.
- Patients with ILD face an elevated risk of developing lung cancer, compounding their prognosis.
- Treatment of lung cancer in ILD patients is complicated by the risk of acute exacerbations, negatively impacting outcomes.
Impact:
- Improved understanding of shared fibrogenesis and carcinogenesis mechanisms.
- Development of multidisciplinary management strategies for co-existing lung cancer and ILD.
- Mitigation of treatment-related complications and improved survival for patients with both conditions.
Related Concept Videos
01:17Other Pulmonary Disorders
890
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
890
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.9K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.9K
01:20COPD: Pathogenesis and Clinical Features
444
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
444
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.9K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.9K
01:30Pulmonary Hypertension: Classification and Pathogenesis
265
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
265
01:22Chronic Obstructive Pulmonary Disease
1.4K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K